# TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC

> **NCT03517618** · PHASE2 · COMPLETED · sponsor: **TTY Biopharm** · enrollment: 41 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** S-1+leucovorin

## Key facts

- **NCT ID:** NCT03517618
- **Lead sponsor:** TTY Biopharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-05
- **Primary completion:** 2015-06-18
- **Final completion:** 2015-06-18
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03517618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03517618, "TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03517618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*